Enveric Biosciences and Restoration Biologics Announce Licensing Agreements to Treat Joint Disease Enveric Biosciences a biotechnology company focused on developing novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders, has announced a significant strategic partnership through…
Devonian Health Group Reports Groundbreaking Findings on Thykamine™’s Superior Anti-Inflammatory Potency Devonian Health Group a clinical-stage biopharmaceutical company focused on pioneering treatments for inflammatory diseases, has announced the remarkable results of its latest in vitro comparative study. The study confirms…
OA Pain Zoetis Updates U.S. Label for Librela® to Enhance Support for Veterinarians and Pet Owners OA Pain Zoetis a global leader in animal health, has announced a key update to the U.S. label for Librela® (bedinvetmab injection). This change…
Marquis Who’s Who Recognizes Dr. Daniel L. Shungu for Leadership in Disease Control Daniel L. Shungu, PhD, has been honored with inclusion in Marquis Who’s Who, a prestigious recognition awarded to individuals with remarkable achievements, leadership, and contributions in their…
Patient-Centric Medidata Leading the Future of Life Sciences with AI-Powered Innovations and Patient-Centric Experiences Patient-Centric Medidata, a Dassault Systèmes brand, continues to solidify its role as a pioneering force in the life sciences industry, reaffirming its commitment to revolutionizing patient…
Nuvation Bio Expands Access to Taletrectinib for Advanced ROS1-Positive NSCLC Patients in the U.S. Nuvation Bio a leading global biopharmaceutical company focused on developing innovative therapies for some of the most pressing unmet needs in oncology, has announced the initiation…
Galderma Leads in Aesthetic Injectables & Weight Loss Research New research reveals that loose or sagging skin on the face and neck is most commonly observed after medication-driven weight loss, with facial changes typically appearing 3-6 months post-treatment in 45%…
Enveric Biosciences Secures Patent Protection for Breakthrough Neuroplastogen EB-003 In a significant milestone for its innovative drug development pipeline, Enveric Biosciences (NASDAQ: ENVB) has announced the receipt of a Notice of Allowance (NOA) from the United States Patent and Trademark…
Ferrer Achieves Compliance Leader Verification™: A Testament to Excellence in Ethics and Corporate Responsibility In a significant milestone for ethical business practices, Ferrer, a global pharmaceutical company headquartered in Barcelona, has been awarded the prestigious Compliance Leader Verification™ by Ethisphere,…
RevBio Secures 10th Patent for TETRANITE®: Expanding Protection for Revolutionary Bone Adhesive Technology In a significant milestone for regenerative medicine, ITS, a clinical-stage medical device company, has been granted its 10th U.S. patent for its groundbreaking TETRANITE® bone adhesive technology.…
TNF Pharmaceuticals Launches Study Series to Preserve Lean Muscle Mass During GLP-1 Weight Loss Treatment TNF Pharmaceuticals, Inc. (Nasdaq: TNFA), a clinical-stage biopharmaceutical company focused on developing innovative therapies for autoimmune and inflammatory conditions, has announced the initiation of its…
Leveragen Inc. and Moonlight Bio Forge Strategic Collaboration to Revolutionize T Cell Therapies for Cancer Treatment Leveragen Inc., a pioneering biotech company based in Boston, has announced a groundbreaking partnership with Moonlight Bio, a Seattle-based biotech firm specializing in advanced…